US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Jazz Pharmaceuticals PLC

110.04

-10.7800-8.92%

Post-market: 112.092.05+1.86%17:41 EDT

Volume:2.17M

Turnover:243.64M

Market Cap:6.68B

PE:12.72

High:117.12

Open:116.48

Low:109.76

Close:120.82

Loading ...

Overview Company News Filings

AMGN's Uplizna Gets FDA Nod for 2nd Rare Autoimmune Disease Indication

SNY's Rilzabrutinib Gets FDA's Orphan Drug Tag for Two Rare Diseases

RBC Raises Price Target on Jazz Pharmaceuticals to $182 From $178, Keeps Outperform Rating

MT Newswires Live

Alkermes Begins Idiopathic Hypersomnia Study on ALKS 2680

VRTX Provides Mixed Updates for Type 1 Diabetes Pipeline Candidates

After a year of 4.3% returns, Jazz Pharmaceuticals plc's (NASDAQ:JAZZ) share price drop last week may have less of an impact on institutional investors

Simply Wall St.

JAZZ or ARGX: Which Is the Better Value Stock Right Now?

Is Jazz Pharmaceuticals (JAZZ) the Best Mid Cap Biotech Stock to Buy?

BEAM's IND for BEAM-302 in Genetic Disorder Study Gets FDA Clearance

LTRN: 2024 Financial Results

Zacks Small Cap Research

Is Jazz Pharmaceuticals plc (JAZZ) a Promising Biotech Stock According to Wall Street Analysts

Why Jazz Pharmaceuticals (JAZZ) is a Top Momentum Stock for the Long-Term

Zacks.com featured highlights include MPLX LP, Leidos, Jazz Pharmaceuticals, Fortinet and Pilgrim's Pride

TPB, ACB and JAZZ: Three Pot Stocks Flowering With Potential Upside

5 High ROE Stocks to Buy as Markets Dip Despite Rate Cut Hopes

4 Top PEG Stocks Based on GARP Approach to Smart Investing

Akari Therapeutics Names Abizer Gaslightwala CEO

MT Newswires Live

HRMY Down 10.8% in Six Months: How Should You Play the Stock?

Jazz Pharmaceuticals to Showcase Research Demonstrating Treatment Benefits of Xywav® (Calcium, Magnesium, Potassium, and Sodium Oxybates) Oral Solution and Epidiolex® (Cannabidiol) at American Academy of Neurology Annual Meeting

THOMSON REUTERS

Jazz Pharmaceuticals to Showcase Research Demonstrating Treatment Benefits of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution and Epidiolex® (cannabidiol) at American Academy of Neurology Annual Meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/JAZZ/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"JAZZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JAZZ\",,,,,undefined,":{"symbol":"JAZZ","market":"US","secType":"STK","nameCN":"Jazz Pharmaceuticals PLC","latestPrice":110.04,"timestamp":1743796800000,"preClose":120.82,"halted":0,"volume":2171302,"hourTrading":{"tag":"盘后","latestPrice":112.09,"preClose":110.04,"latestTime":"17:41 EDT","volume":10271,"amount":1132476.47,"timestamp":1743802875739},"delay":0,"floatShares":58902600,"shares":60732479,"eps":8.648809,"marketStatus":"Market Closed","change":-10.78,"latestTime":"04-04 16:00:00 EDT","open":116.48,"high":117.115,"low":109.76,"amount":243636792.56889,"amplitude":0.060876,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":8.648809,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1744012800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":120.82,"preHourTrading":{"tag":"盘前","latestPrice":116.22,"preClose":120.82,"latestTime":"09:29 EDT","volume":652,"amount":76690.57416,"timestamp":1743773399999},"postHourTrading":{"tag":"盘后","latestPrice":112.09,"preClose":110.04,"latestTime":"17:41 EDT","volume":10271,"amount":1132476.47,"timestamp":1743802875739},"volumeRatio":1.555891195324908,"impliedVol":0.5379,"impliedVolPercentile":0.996},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JAZZ\",,,,,undefined,":{"symbol":"JAZZ","floatShares":58902600,"roa":"4.60%","roe":"14.31%","lyrEps":9.05786,"volumeRatio":1.555891195324908,"shares":60732479,"dividePrice":0,"high":117.115,"amplitude":0.060876,"preClose":120.82,"low":109.76,"week52Low":99.06,"pbRate":"1.63","psRate":"1.64","week52High":148.0568,"institutionHeld":0,"latestPrice":110.04,"eps":8.648809,"divideRate":0,"volume":2171302,"delay":0,"ttmEps":8.648809,"open":116.48,"prevYearClose":123.15,"prevWeekClose":122.92,"prevMonthClose":124.15,"prevQuarterClose":124.15,"fiveDayClose":122.92,"twentyDayClose":138.81,"sixtyDayClose":122.54},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"JAZZ\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2525734293","title":"AMGN's Uplizna Gets FDA Nod for 2nd Rare Autoimmune Disease Indication","url":"https://stock-news.laohu8.com/highlight/detail?id=2525734293","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525734293?lang=en_us&edition=fundamental","pubTime":"2025-04-05 01:10","pubTimestamp":1743786600,"startTime":"0","endTime":"0","summary":"Amgen AMGN announced that the FDA has approved its rare disease drug Uplizna  for a new indication. The regulatory body has now approved Uplizna for the treatment of adults living with immunoglobulin G4-related disease , a rare immune-mediated inflammatory condition. This marks the second approved indication for the drug.Uplizna is currently approved in the United States for treating adults with a rare autoimmune disease called neuromyelitis optica spectrum disorder.Following the nod, Uplizna became the first and only drug approved by the FDA for the treatment of IgG4-RD, a chronic disease with a significant unmet medical need.The FDA had previously granted a breakthrough therapy designation to Uplizna for the treatment of IgG4-RD.Year to date, shares of Amgen have rallied 18.9% compared with the industry’s rise of 1.2%.Uplizna's Nod for IgG4-RD Based on AMGN's MITIGATE Study. Some better-ranked stocks in the biotech sector are Jazz Pharmaceuticals, Inc. JAZZ, Dynavax Technologies Corp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amgns-uplizna-gets-fda-nod-171000251.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2112291526.USD","IE00B2B36J28.USD","BK4566","BK4599","LU0109394709.USD","BK4588","JAZZ","IE00BN0W2W23.USD","LU2468319806.SGD","LU0889565916.HKD","AMGN","LU2242652126.USD","IE0002141913.USD","LU0122379950.USD","LU2089984988.USD","BK4139","BK4581","IE00BFTCPJ56.SGD","BK4534","IE0009355771.USD","LU1023059063.AUD","IE00BN0W2T93.GBP","LU1571399168.USD","BK4532","BK4007","DVAX","BK4533","LU0823416689.USD","LU0868494617.USD","LU1983299246.USD","IE00B4R5TH58.HKD","IE00BN0W2V16.EUR","LU0058720904.USD","IE00BJJMRZ35.SGD","KRYS","LU0289739699.SGD","SG9999001440.SGD","BK4585","LU1061106388.HKD","LU2242646821.SGD","LU0320765992.SGD","IE00BJT1NW94.SGD","LU1057294990.SGD"],"gpt_icon":0},{"id":"2524296191","title":"SNY's Rilzabrutinib Gets FDA's Orphan Drug Tag for Two Rare Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2524296191","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524296191?lang=en_us&edition=fundamental","pubTime":"2025-04-03 23:27","pubTimestamp":1743694020,"startTime":"0","endTime":"0","summary":"Sanofi SNY announced that the FDA has granted orphan drug designation to its investigational BTK inhibitor, rilzabrutinib, for the treatment of warm autoimmune hemolytic anemia  and IgG4-related disease .The candidate is being developed in separate mid-stage studies for treating wAIHA and IgG4-RD, two rare diseases.Currently, there are no approved therapies for treating wAIHA and IgG4-RD. Both diseases have a significant unmet medical need.The FDA grants orphan drug designation to support the development of medicines for rare disorders that affect less than 200,000 patients in the United States.Sanofi has developed rilzabrutinib for treating immune thrombocytopenia , another rare, complex autoimmune disorder.A regulatory application seeking approval for rilzabrutinib for treating ITP is currently under review in the United States. A final decision from the FDA is expected on Aug. 29, 2025. The regulatory body has previously granted a fast-track designation and an orphan drug designatio","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/snys-rilzabrutinib-gets-fdas-orphan-152700727.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0889565916.HKD","IE00BN0W2V16.EUR","IE00BFXG1179.USD","KRYS","BK4532","BK4139","IE00BN0W2T93.GBP","JAZZ","LU0320765992.SGD","LU0823416689.USD","SNY","DVAX","BK4585","BK4533","IE00BN0W2W23.USD","BK4588","BK4007","LU0109394709.USD"],"gpt_icon":0},{"id":"2524258985","title":"RBC Raises Price Target on Jazz Pharmaceuticals to $182 From $178, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2524258985","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524258985?lang=en_us&edition=fundamental","pubTime":"2025-04-03 19:23","pubTimestamp":1743679437,"startTime":"0","endTime":"0","summary":"Jazz Pharmaceuticals (JAZZ) has an average rating of buy and mean price target of $193.82, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["JAZZ"],"gpt_icon":0},{"id":"2524416973","title":"Alkermes Begins Idiopathic Hypersomnia Study on ALKS 2680","url":"https://stock-news.laohu8.com/highlight/detail?id=2524416973","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524416973?lang=en_us&edition=fundamental","pubTime":"2025-04-02 21:33","pubTimestamp":1743600780,"startTime":"0","endTime":"0","summary":"Alkermes plc ALKS announced that it has initiated the phase II Vibrance-3 study, evaluating the novel, investigational and oral orexin 2 receptor agonist, ALKS 2680, in adults with idiopathic hypersomnia , a rare, chronic and neurological sleep disorder.The double-blind, placebo-controlled study will evaluate the safety and efficacy of ALKS 2680 compared with placebo in adults with IH. The primary endpoint of the Vibrance-3 study will check, by dose level, whether treatment with ALKS 2680 leads to a greater decrease in sleepiness versus placebo alone, as measured by the change in Epworth Sleepiness Scale score.In the study, participants will be randomized to receive one of the three doses of ALKS 2680  or placebo to be taken once daily for eight weeks.Secondary endpoints of the Vibrance-3 study are changes in the Idiopathic Hypersomnia Severity Scale score and incidence of adverse events.Besides IH, ALKS 2680 is also being developed for the treatment of narcolepsy type 1 and type 2.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alkermes-begins-idiopathic-hypersomnia-study-133300611.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4505","ALKS","LU0109394709.USD","IE00BN0W2V16.EUR","LU0889565916.HKD","LU0320765992.SGD","BK4533","AXSM","JAZZ","BK4007","BK4585","IE00BN0W2T93.GBP","BK4532","IE00BN0W2W23.USD","BK4139","LU0823416689.USD","KRYS"],"gpt_icon":0},{"id":"2524449231","title":"VRTX Provides Mixed Updates for Type 1 Diabetes Pipeline Candidates","url":"https://stock-news.laohu8.com/highlight/detail?id=2524449231","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524449231?lang=en_us&edition=fundamental","pubTime":"2025-04-01 22:55","pubTimestamp":1743519300,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals Incorporated VRTX announced updates on its two novel investigational candidates, zimislecel  and VX-264, which are being developed in separate studies for the treatment of type 1 diabetes .Zimislecel is designed for the transplantation of islet cells alone, using immunosuppression to protect the implanted cells. The candidate is in pivotal late-stage development for treating patients with T1D with severe hypoglycemic events  and impaired awareness of hypoglycemia.Meanwhile, VX-264 is being developed following a unique approach that involves the implantation of the islet cells inside an immunoprotective device.Year to date, shares of Vertex have rallied 20.4% compared with the industry’s rise of 3.5%.In the past 60 days, estimates for Jazz Pharmaceuticals’ earnings per share have increased from $22.06 to $23.33 for 2025. During the same time, earnings per share estimates for 2026 have increased from $23.13 to $23.35. Year to date, shares of JAZZ have risen 0.8%.In","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vrtx-provides-mixed-updates-type-145500721.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4567","IE00B2B36J28.USD","IE00BN0W2V16.EUR","IE00B19Z9Z06.USD","JAZZ","DVAX","LU2362541513.USD","IE0009355771.USD","LU0109394709.USD","LU1815336091.USD","IE00B19Z3581.USD","LU0058720904.USD","LU2236285917.USD","LU1093756168.USD","LU0566484027.USD","IE00B4R5TH58.HKD","LU0256863811.USD","LU0823416689.USD","LU2456880835.USD","VRTX","IE00BZ9MQY76.HKD","BK4533","BK4023","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","KRYS","IE0002141913.USD","LU0320765992.SGD","IE00BFTCPJ56.SGD","IE00B19Z3B42.SGD","LU0757428866.USD","IE00B19Z9P08.USD","IE00BN0W2W23.USD","LU1585245621.USD","LU2462157665.USD","LU1093756325.SGD","IE00BN0W2T93.GBP","VERX","LU2237438978.USD","LU1035775433.USD","LU0234570918.USD","LU2324357040.USD","LU2362541273.HKD","BK4007","LU2362540622.SGD","LU2417539215.USD","LU1430594728.SGD","BK4588","BK4532","LU1069344957.HKD"],"gpt_icon":0},{"id":"2524511989","title":"After a year of 4.3% returns, Jazz Pharmaceuticals plc's (NASDAQ:JAZZ) share price drop last week may have less of an impact on institutional investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2524511989","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524511989?lang=en_us&edition=fundamental","pubTime":"2025-04-01 20:35","pubTimestamp":1743510940,"startTime":"0","endTime":"0","summary":"Given the large stake in the stock by institutions, Jazz Pharmaceuticals' stock price might be vulnerable to their trading decisions. If you want to know who really controls Jazz Pharmaceuticals plc , then you'll have to look at the makeup of its share registry. We can see that institutions own the lion's share in the company with 65% ownership. Put another way, the group faces the maximum upside potential .No shareholder likes losing money on their investments, especially institutional investors who saw their holdings drop 13% in value last week. However, the 4.3% one-year returns may have helped alleviate their overall losses. They should, however, be mindful of further losses in the future.Let's delve deeper into each type of owner of Jazz Pharmaceuticals, beginning with the chart below.Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There are plenty of analysts covering th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/4-3-returns-jazz-pharmaceuticals-123540157.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BGHQF748.EUR","BK4007","BK4532","NDAQ","MNQmain","PSQ","LU0109394709.USD","USJW.SI","TQQQ",".IXIC","LU0889565916.HKD","IE00B3QW5Z07.USD","USAW.SI","IE00BKPKM429.USD","JAZZ","NQmain","IE00BN0W2W23.USD","SQQQ","IE00BN0W2T93.GBP","LU0320765992.SGD","LU2095319765.USD","BK4112","LU0823416689.USD","LU2210150020.SGD","QLD","BK4588","QID","NVIW.SI","TSYW.SI","BK4585","IE00BN0W2V16.EUR","LU2210149790.SGD","BK4533","IE00B64PRP62.GBP"],"gpt_icon":1},{"id":"2524920137","title":"JAZZ or ARGX: Which Is the Better Value Stock Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2524920137","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524920137?lang=en_us&edition=fundamental","pubTime":"2025-03-31 23:40","pubTimestamp":1743435613,"startTime":"0","endTime":"0","summary":"Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Jazz Pharmaceuticals  and argenex SE . But which of these two companies is the best option for those looking for undervalued stocks?We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with specific traits.Jazz Pharmaceuticals and argenex SE are sporting Zacks Ranks of #2  and #3 , respectively, right now. Investors should feel comfortable knowing that JAZZ likely has seen a stronger improvement to its earnings outlook than ARGX has recently. But this is only part of the picture for value investors.JAZZ currently has a forward P/E ratio of 5.27, while ARGX has a forward P/E of 47.10. We also note that JAZZ has a PEG ratio of 0.72. This metric is ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/jazz-argx-better-value-stock-154013806.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4505","ARGX","BK4139","LU0823416689.USD","BK4007","LU0889565916.HKD","LU0109394709.USD","IE00BN0W2W23.USD","BK4588","BK4533","LU0320765992.SGD","BK4532","IE00BN0W2T93.GBP","BK4585","IE00BN0W2V16.EUR","JAZZ"],"gpt_icon":0},{"id":"2523612313","title":"Is Jazz Pharmaceuticals (JAZZ) the Best Mid Cap Biotech Stock to Buy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2523612313","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523612313?lang=en_us&edition=fundamental","pubTime":"2025-03-30 04:15","pubTimestamp":1743279319,"startTime":"0","endTime":"0","summary":"We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at where Jazz Pharmaceuticals plc  stands against the other best mid cap biotech stocks to buy.In some respects, investors and analysts are always looking for a clear pathway for biotech as a sector to perform better. However, Holz said we are in a tough place if a quarter of the index is filled with companies with more cash than the market cap. That is why he suggested, which some people consider somewhat hyperbolic, getting rid of the tail here, as there are too many assets out there.We sifted through stock screeners, financial media reports, and ETFs to compile a list of 30 biotech stocks with a market cap between $2 billion and $10 billion. We then selected the top 10 with the highest number of hedge fund holders, as of Q4 2024,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/jazz-pharmaceuticals-jazz-best-mid-201519209.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BN0W2V16.EUR","LU0109394709.USD",".IXIC","LU0889565916.HKD","JAZZ","LU0320765992.SGD","IE00BN0W2T93.GBP","QLD","MNQmain","TQQQ","PSQ","BK4532","IE00BN0W2W23.USD","BK4585","LU0823416689.USD","BK4132","BK4007","BK4588","VOD","TSYW.SI","BK4533","NVIW.SI","NQmain","USAW.SI","USJW.SI","SQQQ","QID"],"gpt_icon":1},{"id":"2522843502","title":"BEAM's IND for BEAM-302 in Genetic Disorder Study Gets FDA Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2522843502","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522843502?lang=en_us&edition=fundamental","pubTime":"2025-03-28 21:26","pubTimestamp":1743168360,"startTime":"0","endTime":"0","summary":"Beam Therapeutics Inc. BEAM announced that the FDA has cleared the investigational new drug  application to begin clinical studies on its pipeline candidate, BEAM-302, for the treatment of alpha-1 antitrypsin deficiency  in the United States.BEAM-302 is a liver-targeting lipid-nanoparticle  formulation of base editing reagents designed to correct the disease-causing PiZ mutation.AATD is an inherited genetic disorder that can cause early onset of emphysema and liver disease. Currently, there are no approved curative treatments for the given indication.In June 2024, Beam Therapeutics dosed the first patient in a phase I/II study on BEAM-302 for the treatment of AATD in the United Kingdom. The candidate has also received clinical trial authorization from New Zealand, Australia, the Netherlands and Ireland.Year to date, shares of Beam Therapeutics have declined 10.6% against the industry’s increase of 3.3%.JAZZ’s earnings beat estimates in three of the trailing four quarters while missing ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/beams-ind-beam-302-genetic-132600403.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BN0W2V16.EUR","LU0320765992.SGD","BK4533","BEAM","BK4160","IE00BN0W2T93.GBP","BK4588","LU0889565916.HKD","BK4556","BK4585","IE00BN0W2W23.USD","LU0823416689.USD","AAT","BK4007","BK4532","KRYS","LU0109394709.USD","DVAX","JAZZ","BK4535","BK4611","BK4505","BK4139"],"gpt_icon":0},{"id":"2522501367","title":"LTRN: 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2522501367","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522501367?lang=en_us&edition=fundamental","pubTime":"2025-03-28 18:20","pubTimestamp":1743157200,"startTime":"0","endTime":"0","summary":"Lantern Pharma, Inc  reports 2024 results highlighting several achievements including progress on its HARMONIC, LP-184 and LP-284 trials, a portfolio of expedited designations in multiple indications and advances in the RADR platform with modules that offer predictive algorithms for blood brain barrier  penetration and antibody drug conjugate  design.On March 27th, 2025, Lantern announced 2024 financial and operational results, filed its Form 10-K with the SEC and hosted a video webcast to review accomplishments. A slide deck was included to guide the discussion. In the financial sphere, Lantern generated no revenues in 2024 and incurred operating expense of $22.2 million, producing a net loss of  million or  per share.General & administrative expenses were $6.1 million, rising 2% from $6.0 million. Higher professional fees were partially offset by lower wage and benefit costs, a decrease in insurance expense and a decline in stock","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ltrn-2024-financial-results-102000980.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVIW.SI","TSYW.SI","BK4231","LU0109394709.USD",".IXIC","JAZZ","IE00BN0W2W23.USD","LU0889565916.HKD","LTRN","CMRX","QID","ADC","MNQmain","BK4583","USAW.SI","BK4139","IE00BN0W2T93.GBP","BK4532","SQQQ","BK4007","BK4080","PSQ","BK4533","LU0823416689.USD","IE00BN0W2V16.EUR","QLD","NQmain","LU0320765992.SGD","TQQQ","USJW.SI"],"gpt_icon":1},{"id":"2522831877","title":"Is Jazz Pharmaceuticals plc (JAZZ) a Promising Biotech Stock According to Wall Street Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2522831877","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522831877?lang=en_us&edition=fundamental","pubTime":"2025-03-26 05:39","pubTimestamp":1742938758,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we are going to look at where Jazz Pharmaceuticals plc  stands against other biotech stocks.Biotech Sector Set for Growth Amid Innovation and Investor Interest. The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention. The industry has recovered from a challenging 2024 and is poised for significant expansion led by advances in personalized medicine, AI-driven drug discovery, and growing demand for biologics. MarketsandMarkets predicted that the global biotech market would expand by a strong 13%, from $483.0 billion in 2024 to $546.0 billion in 2025. This expansion demonstrates the sector’s tenacity and promise for growth.For this article, we shortlisted stocks that met the following criteria: a market capitalization of over $2 billion, co","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/jazz-pharmaceuticals-plc-jazz-promising-213918115.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVIW.SI","LU0320765992.SGD","NQmain","IE00BN0W2T93.GBP","LU0823416689.USD","USAW.SI","JAZZ","BK4532","LU0109394709.USD","IE00BN0W2V16.EUR","QID","QLD","PSQ","BK4007","TSYW.SI","TQQQ","BK4533","MNQmain","SQQQ",".IXIC","USJW.SI","IE00BN0W2W23.USD","LU0889565916.HKD"],"gpt_icon":1},{"id":"2522774474","title":"Why Jazz Pharmaceuticals (JAZZ) is a Top Momentum Stock for the Long-Term","url":"https://stock-news.laohu8.com/highlight/detail?id=2522774474","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522774474?lang=en_us&edition=fundamental","pubTime":"2025-03-24 21:50","pubTimestamp":1742824207,"startTime":"0","endTime":"0","summary":"Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike.Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your preferred way of investing is to use the Zacks Style Scores, which are indicators that rate stocks based on three widely-followed investing types: value, growth, and momentum.Is This 1 Momentum Stock a Screaming Buy Right Now?Momentum investors, who live by the saying \"the trend is your friend,\" are most interested in taking advantage of upward or downward trends in a stock's price or earnings outlook. Utilizing one-week price change and the monthly percentage change in earnings estimates, among other factors, the Momentum Style Score can help determine favorable times to buy high-momentum stocks.Dublin, Ireland-based Jazz Pharmaceuticals is a specialty biopharmaceutical company with a focus on neuroscience and oncology.Jazz Pharmac","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-jazz-pharmaceuticals-jazz-top-135007940.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BN0W2T93.GBP","BK4533","IE00BN0W2V16.EUR","BK4532","JAZZ","LU0823416689.USD","LU0109394709.USD","LU0889565916.HKD","BK4007","LU0320765992.SGD","IE00BN0W2W23.USD"],"gpt_icon":0},{"id":"2521714060","title":"Zacks.com featured highlights include MPLX LP, Leidos, Jazz Pharmaceuticals, Fortinet and Pilgrim's Pride","url":"https://stock-news.laohu8.com/highlight/detail?id=2521714060","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521714060?lang=en_us&edition=fundamental","pubTime":"2025-03-24 16:26","pubTimestamp":1742804760,"startTime":"0","endTime":"0","summary":"Chicago, IL – March 24, 2025 – Stocks in this week’s article are — MPLX LP MPLX, Leidos Holdings, Inc. LDOS, Jazz Pharmaceuticals plc JAZZ, Fortinet, Inc. FTNT and Pilgrim's Pride Corp. PPC.5 High ROE Stocks to Buy as Market Dips Despite Rate-Cut Hopes. However, identifying cash-rich stocks alone does not make for a solid investment proposition unless it is backed by attractive efficiency ratios, such as return on equity . A high ROE ensures that the company is reinvesting cash at a high rate of return. MPLX LP, Leidos Holdings, Inc., Jazz Pharmaceuticals plc, Fortinet, Inc. and Pilgrim's Pride Corp. are some of the stocks with high ROE to profit from.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zacks-com-featured-highlights-mplx-082600814.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0109394709.USD","LU1917777945.USD","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","LU0823416689.USD","IE00BN0W2V16.EUR","BK4590","BK4212","IE0008368304.USD","PPC","BK4123","LU2286300806.USD","ROE","LU0889565916.HKD","BK4560","BK4097","BK4533","LU0079474960.USD","LU2023250843.SGD","JAZZ","BK4007","BK4585","LU0348723411.USD","BK4144","BK4532","FTNT","LU0006061336.USD","LU1974910355.USD","BK4588","LU0320765992.SGD","MPLX","LDOS","LU2106854487.HKD","LU2023250504.SGD"],"gpt_icon":0},{"id":"2521448302","title":"TPB, ACB and JAZZ: Three Pot Stocks Flowering With Potential Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2521448302","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521448302?lang=en_us&edition=fundamental","pubTime":"2025-03-23 04:09","pubTimestamp":1742674145,"startTime":"0","endTime":"0","summary":"After bursting onto the scene several years ago with considerable fanfare, much of the hype about cannabis stocks has quietly died down, and share prices have largely followed suit. Here, we’ll examine three profitable and cheap cannabis-related stocks that offer investors long-term value and potential upside: Turning Point Brands , Aurora Cannabis , and Jazz Pharmaceuticals .Discover stocks' market position with detailed  competitor analyses.Having been illegal for decades, cannabis is seeing the light of day following spates of deregulation across the U.S., Canada, Australia, and Europe over the past decade. Cannabis stocks, otherwise known as pot stocks, have understandably emerged to mop up the huge pent-up demand for cannabis products. Whether it be medicinal, industrial, or recreational, the cannabis market is now a commercial entity being monetized across the U.S. and Canada.Turning Point offers both momentum and value and has much potential going forward","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/tpb-acb-jazz-three-pot-200905362.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tpb-acb-jazz-three-pot-200905362.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TLRY","BK4557","LU0109394709.USD","LU1228905037.USD","LU0545562505.USD","LU0690374961.EUR","IE00BN0W2T93.GBP","LU0690374615.EUR","IE00BN0W2W23.USD","LU0426417589.USD","LU0949170772.SGD","LU2404859667.USD","LU0823416689.USD","BK4596","LU0426412945.USD","LU2404859741.USD","LU1043141396.HKD","IE00BN0W2V16.EUR","LU0738911758.USD","LU0994945656.USD","GB00B4QBRK32.GBP","LU0661504455.SGD","LU1066051225.USD","SG9999001440.SGD","SG9999011175.SGD","LU1506573853.SGD","BK4547","LU0889565916.HKD","BK4533","BK4075","JAZZ","BK4007","BK4585","LU1066051811.HKD","LU1121112475.USD","BK4532","PM","TPB","GB00B4LPDJ14.GBP","ACB","MJUS","BK4588","LU0320765992.SGD","IE000M9KFDE8.USD","LU1066053197.SGD","BK4566","LU1043141123.HKD","LU0314106906.USD","LU1066051498.USD","SG9999003800.SGD"],"gpt_icon":0},{"id":"2521625845","title":"5 High ROE Stocks to Buy as Markets Dip Despite Rate Cut Hopes","url":"https://stock-news.laohu8.com/highlight/detail?id=2521625845","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521625845?lang=en_us&edition=fundamental","pubTime":"2025-03-22 00:04","pubTimestamp":1742573040,"startTime":"0","endTime":"0","summary":"Despite a sharp rally following the Federal Reserve's assurance of two rate cuts in 2025, the broader equity markets trended down on average over the past few trading days, as President Trump’s on-aga","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/5-high-roe-stocks-buy-160400821.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BN0W2V16.EUR","LU0109394709.USD","ROE","LU0889565916.HKD","JAZZ","BK4097","LU0320765992.SGD","LU2106854487.HKD","LU1917777945.USD","MPLX","IE00BN0W2T93.GBP","LDOS","BK4532","IE00BN0W2W23.USD","BK4144","BK4585","LU0823416689.USD","BK4007","BK4588","LU0348723411.USD","LU0079474960.USD","BK4590","BK4560","LU2286300806.USD","BK4533","LU2023250504.SGD","LU2023250843.SGD","BK4123","FTNT","LU1974910355.USD","PPC","LU0006061336.USD","BK4212","IE0008368304.USD"],"gpt_icon":0},{"id":"2520468978","title":"4 Top PEG Stocks Based on GARP Approach to Smart Investing","url":"https://stock-news.laohu8.com/highlight/detail?id=2520468978","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520468978?lang=en_us&edition=fundamental","pubTime":"2025-03-20 21:38","pubTimestamp":1742477880,"startTime":"0","endTime":"0","summary":"In the equity market, investments always need to be prudently hedged in order to overcome uncertainties and limit losses related to external shocks. A question that often arises is whether one should resort to a value strategy that seeks discounted stocks or opt for growth investing in times of extreme market instability.The investing track of the Oracle of Omaha over the past few decades and his gradual shift from being a pure-play value investor to a GARP  investor might give us all the answers.Several stocks that have surged significantly in recent years demonstrate the overwhelming success of this hybrid investing strategy over pure-play value and growth investments. Here, we will discuss the success of four such stocks. These are Jazz Pharmaceuticals JAZZ, Fresenius Medical Care AG & Co. FMS Dana Incorporated DAN and Itron Inc ITRI.The GARP theory enables strategic mingling of growth and value-investing principles, which gives us a hybrid strategy by utilizing the best features of","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/4-top-peg-stocks-based-133800135.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4157","LU0823416689.USD","PEG","LU0320765992.SGD","BK4588","BK4124","IE00BMG7P819.SGD","JAZZ","LU2048586759.USD","BK4533","FMS","IE00BN0W2T93.GBP","IE00BMG7P587.USD","BK4208","LU0889565916.HKD","DAN","IE00BD4GTW91.USD","IE00BMG7P926.USD","IE00BN0W2V16.EUR","BK4007","IE00BGHQF417.EUR","IE00BN0W2W23.USD","IE00B3CCJ633.GBP","IE00BD4GTT62.SGD","BK4585","IE00BMG7P694.USD","BK4196","GARP","ITRI","LU0109394709.USD","IE00B2PGVK34.USD","IE00BD4GTV84.USD","BK4532"],"gpt_icon":0},{"id":"2520281451","title":"Akari Therapeutics Names Abizer Gaslightwala CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2520281451","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520281451?lang=en_us&edition=fundamental","pubTime":"2025-03-20 21:13","pubTimestamp":1742476429,"startTime":"0","endTime":"0","summary":"Akari Therapeutics  said Thursday that it has appointed Abizer Gaslightwala as president and chief executive officer, starting April 21.Gaslightwala was most recently senior vice president and franchise head for US Oncology at Jazz Pharmaceuticals , Akari said.Gaslightwala was appointed to Akari's board in December, the company said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0889565916.HKD","LU0823416689.USD","BK4139","IE00BN0W2T93.GBP","BK4532","IE00BN0W2V16.EUR","JAZZ","LU0320765992.SGD","IE00BN0W2W23.USD","AKTX","BK4007","LU0109394709.USD","LENZ","BK4533"],"gpt_icon":0},{"id":"2520199470","title":"HRMY Down 10.8% in Six Months: How Should You Play the Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2520199470","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520199470?lang=en_us&edition=fundamental","pubTime":"2025-03-20 00:14","pubTimestamp":1742400840,"startTime":"0","endTime":"0","summary":"Shares of Harmony Biosciences HRMY have lost 10.8% in the past six months compared with the industry’s decline of 9.7%. The stock has also underperformed the S&P 500 index during this timeframe.The stock was hit last month after the company announced that it received a Refusal to File  letter from the FDA for pitolisant for the treatment of excessive daytime sleepiness  in adult patients with idiopathic hypersomnia .Nonetheless, the fourth-quarter results reported on Feb. 25 were better-than-expected and shares recovered a bit.Let’s dig deeper and understand the company’s strengths and weaknesses in detail to understand how to play the stock in such a scenario.HRMY’s Efforts to Expand Wakix’s Label Suffer Setback. The company was looking to expand the drug’s label for EDS in adult patients with IH. The supplemental new drug application  for pitolisant in IH was submitted in the fourth quarter based on data from the INTUNE study and additional sources.The company targets to initiate a p","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/hrmy-down-10-8-six-161400902.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HRMY","IH","BK4085","JAZZ","LU0320765992.SGD","BK4533","BK4563","BK4585","LU0823416689.USD","FXS","LU0109394709.USD","IE00BN0W2V16.EUR","BK4007","AXSM","BK4532","IE00BN0W2T93.GBP","BK4505","BK4510","LU0889565916.HKD","IE00BN0W2W23.USD"],"gpt_icon":0},{"id":"2520024869","title":"Jazz Pharmaceuticals to Showcase Research Demonstrating Treatment Benefits of Xywav® (Calcium, Magnesium, Potassium, and Sodium Oxybates) Oral Solution and Epidiolex® (Cannabidiol) at American Academy of Neurology Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2520024869","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520024869?lang=en_us&edition=fundamental","pubTime":"2025-03-19 19:30","pubTimestamp":1742383803,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nTUA6LS9JL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BN0W2W23.USD","BK4007","BK4532","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","BK4533","LU0320765992.SGD","LU0109394709.USD","JAZZ","LU0823416689.USD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2520887771","title":"Jazz Pharmaceuticals to Showcase Research Demonstrating Treatment Benefits of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution and Epidiolex® (cannabidiol) at American Academy of Neurology Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2520887771","media":"PR Newswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520887771?lang=en_us&edition=fundamental","pubTime":"2025-03-19 19:30","pubTimestamp":1742383800,"startTime":"0","endTime":"0","summary":"Novel analysis of real-worldEpidiolex treatment patterns underscore importance of dose optimization for improved patient persistence. Data presented at the meeting includes an updated presentation of top-line results of the open-label, single-arm, Phase 4 DUET  trial, evaluating the effectiveness and safety of low-sodium oxybate, Xywav  oral solution, on key sleep outcomes and daytime symptoms, including excessive daytime sleepiness , in adults with narcolepsy or idiopathic hypersomnia . Notably, the results from DUET demonstrated statistically significant improvements from baseline to end of treatment in Epworth Sleepiness Scale  scores, reduced sleep stage shifts, increased deep sleep and reduced number of awakenings among adults with narcolepsy treated with Xywav. In adults with IH, Xywav treatment also showed improvements in ESS and Idiopathic Hypersomnia Severity Scale scores. Further, new patient-reported data from DUET demonstrated the association of Xywav treatment with improve","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/jazz-pharmaceuticals-showcase-research-demonstrating-113000459.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/jazz-pharmaceuticals-showcase-research-demonstrating-113000459.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AFG","JAZZ"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/JAZZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-25","symbol":"JAZZ","fiscalQuarterEnding":"2024/12","expectedEps":4.98,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740459600000,"reportTimeType":"post","actualEps":5.7},{"market":"US","date":"2024-11-06","symbol":"JAZZ","fiscalQuarterEnding":"2024/09","expectedEps":4.54,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"post","actualEps":5.86},{"market":"US","date":"2024-07-31","symbol":"JAZZ","fiscalQuarterEnding":"2024/06","expectedEps":3.8,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722398400000,"reportTimeType":"post","actualEps":4.67},{"market":"US","date":"2024-05-01","symbol":"JAZZ","fiscalQuarterEnding":"2024/03","expectedEps":3.53,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1714536000000,"reportTimeType":"post","actualEps":1.98},{"market":"US","date":"2024-02-28","symbol":"JAZZ","fiscalQuarterEnding":"2023/12","expectedEps":4.44,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1709096400000,"reportTimeType":"post","actualEps":4.4}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"JAZZ\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"JAZZ\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2778,"buy":0.6111,"hold":0.1111,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6111,"analysts":18,"updateTime":1741406400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/JAZZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"JAZZ","date":"2025-04-04","current":13.100225,"percent":0.418908,"low":-540.707731,"twenty":-53.254107,"median":16.631892,"eighty":47.178258,"high":261.103916,"avg":-24.497553,"sd":147.379497,"marketCap":7337698112},"quantilePoints":[{"date":"2020-04-09","current":11.764713,"twenty":16.011074,"median":23.590528,"eighty":93.430324,"marketCap":6157262335},{"date":"2020-04-17","current":11.925594,"twenty":15.893575,"median":23.551374,"eighty":93.482872,"marketCap":6241462294},{"date":"2020-04-24","current":11.492287,"twenty":15.777103,"median":23.525458,"eighty":93.482872,"marketCap":6014683737},{"date":"2020-05-01","current":11.753987,"twenty":15.561885,"median":23.492078,"eighty":93.482872,"marketCap":6151649004},{"date":"2020-05-08","current":21.79795,"twenty":15.544862,"median":23.450679,"eighty":91.916942,"marketCap":6110684847},{"date":"2020-05-15","current":21.94006,"twenty":15.544862,"median":23.392394,"eighty":42.214625,"marketCap":6150522706},{"date":"2020-05-22","current":21.630183,"twenty":15.544862,"median":23.339438,"eighty":41.624405,"marketCap":6063654042},{"date":"2020-05-29","current":23.550629,"twenty":15.544862,"median":23.327232,"eighty":41.24471,"marketCap":6602018435},{"date":"2020-06-05","current":23.810984,"twenty":15.544862,"median":23.318894,"eighty":41.067446,"marketCap":6675004563},{"date":"2020-06-12","current":20.66724,"twenty":15.544862,"median":23.255544,"eighty":40.665441,"marketCap":5793709409},{"date":"2020-06-19","current":22.501389,"twenty":15.544862,"median":23.218871,"eighty":40.416054,"marketCap":6307881748},{"date":"2020-06-26","current":21.31087,"twenty":15.544862,"median":23.192648,"eighty":39.709601,"marketCap":5974140176},{"date":"2020-07-02","current":21.668223,"twenty":15.544862,"median":23.134439,"eighty":39.216897,"marketCap":6074317994},{"date":"2020-07-10","current":21.046311,"twenty":15.544862,"median":23.080444,"eighty":38.856824,"marketCap":5899975382},{"date":"2020-07-17","current":21.330613,"twenty":15.544862,"median":23.036139,"eighty":38.711158,"marketCap":5979674862},{"date":"2020-07-24","current":22.288161,"twenty":15.544862,"median":22.953976,"eighty":38.420917,"marketCap":6248107138},{"date":"2020-07-31","current":21.372074,"twenty":15.544862,"median":22.896473,"eighty":37.960459,"marketCap":5991297703},{"date":"2020-08-07","current":52.479992,"twenty":15.544862,"median":22.890616,"eighty":37.898264,"marketCap":6992224196},{"date":"2020-08-14","current":51.722429,"twenty":15.544862,"median":22.890616,"eighty":37.898264,"marketCap":6891289488},{"date":"2020-08-21","current":51.497657,"twenty":15.544862,"median":22.890616,"eighty":37.898264,"marketCap":6861341827},{"date":"2020-08-28","current":55.685068,"twenty":15.544862,"median":22.890616,"eighty":37.898264,"marketCap":7419255655},{"date":"2020-09-04","current":54.819281,"twenty":15.544862,"median":22.890616,"eighty":37.898264,"marketCap":7303901702},{"date":"2020-09-11","current":56.942123,"twenty":15.544862,"median":22.890616,"eighty":37.898264,"marketCap":7586740720},{"date":"2020-09-18","current":59.064965,"twenty":15.544862,"median":22.890616,"eighty":37.898264,"marketCap":7869579738},{"date":"2020-09-25","current":58.09928,"twenty":15.544862,"median":22.890616,"eighty":37.898264,"marketCap":7740915714},{"date":"2020-10-02","current":59.730955,"twenty":15.544862,"median":22.890616,"eighty":37.898264,"marketCap":7958313548},{"date":"2020-10-09","current":64.688416,"twenty":15.544862,"median":22.890616,"eighty":37.898264,"marketCap":8618825843},{"date":"2020-10-16","current":62.424051,"twenty":15.544862,"median":22.890616,"eighty":37.898264,"marketCap":8317130891},{"date":"2020-10-23","current":62.544762,"twenty":15.544862,"median":22.890616,"eighty":37.898264,"marketCap":8333213894},{"date":"2020-10-30","current":59.980701,"twenty":15.544862,"median":22.890616,"eighty":37.898264,"marketCap":7991588727},{"date":"2020-11-06","current":46.23609,"twenty":15.544862,"median":22.890616,"eighty":37.898264,"marketCap":8285229832},{"date":"2020-11-13","current":45.738626,"twenty":15.544862,"median":22.890616,"eighty":37.898264,"marketCap":8196087422},{"date":"2020-11-20","current":44.491859,"twenty":15.544862,"median":22.890616,"eighty":37.898264,"marketCap":7972674258},{"date":"2020-11-27","current":44.547824,"twenty":15.544862,"median":22.890616,"eighty":37.898264,"marketCap":7982702779},{"date":"2020-12-04","current":46.857918,"twenty":15.544862,"median":22.890616,"eighty":37.898264,"marketCap":8396657844},{"date":"2020-12-11","current":45.2536,"twenty":15.544862,"median":22.890616,"eighty":37.898264,"marketCap":8109173573},{"date":"2020-12-18","current":46.823718,"twenty":15.544862,"median":22.890616,"eighty":37.898264,"marketCap":8390529303},{"date":"2020-12-24","current":48.900626,"twenty":15.544862,"median":22.890616,"eighty":37.898264,"marketCap":8762698863},{"date":"2020-12-31","current":51.316432,"twenty":15.544862,"median":22.890616,"eighty":37.898264,"marketCap":9195596690},{"date":"2021-01-08","current":50.181594,"twenty":15.544862,"median":22.890616,"eighty":37.898264,"marketCap":8992240568},{"date":"2021-01-15","current":52.143464,"twenty":15.544862,"median":22.890616,"eighty":37.898264,"marketCap":9343795946},{"date":"2021-01-22","current":52.435724,"twenty":15.544862,"median":22.890616,"eighty":37.898264,"marketCap":9396167111},{"date":"2021-01-29","current":48.347199,"twenty":15.544862,"median":22.890616,"eighty":37.898264,"marketCap":8663527933},{"date":"2021-02-05","current":49.28445,"twenty":15.544862,"median":22.890616,"eighty":37.898264,"marketCap":8831477720},{"date":"2021-02-12","current":52.616985,"twenty":15.544862,"median":22.890616,"eighty":37.898264,"marketCap":9428647936},{"date":"2021-02-19","current":50.443456,"twenty":15.544862,"median":22.890616,"eighty":37.898264,"marketCap":9039164629},{"date":"2021-02-26","current":39.665933,"twenty":15.544862,"median":22.890616,"eighty":37.798972,"marketCap":9464926265},{"date":"2021-03-05","current":38.889327,"twenty":15.539951,"median":22.886589,"eighty":37.680039,"marketCap":9279615581},{"date":"2021-03-12","current":39.543187,"twenty":15.539951,"median":22.886589,"eighty":37.680039,"marketCap":9435637038},{"date":"2021-03-19","current":40.683311,"twenty":15.539951,"median":22.886589,"eighty":37.680039,"marketCap":9707688894},{"date":"2021-03-26","current":39.755632,"twenty":15.544862,"median":22.890616,"eighty":37.794835,"marketCap":9486329931},{"date":"2021-04-01","current":38.995549,"twenty":15.544862,"median":22.890616,"eighty":37.794835,"marketCap":9304962027},{"date":"2021-04-09","current":38.098557,"twenty":15.539951,"median":22.886589,"eighty":37.680039,"marketCap":9090925370},{"date":"2021-04-16","current":39.868936,"twenty":15.539951,"median":22.886589,"eighty":37.680039,"marketCap":9513366140},{"date":"2021-04-23","current":39.356707,"twenty":15.539951,"median":22.886589,"eighty":37.680039,"marketCap":9391139944},{"date":"2021-04-30","current":38.806709,"twenty":15.539951,"median":22.886589,"eighty":37.680039,"marketCap":9259901678},{"date":"2021-05-07","current":20.445615,"twenty":15.539951,"median":22.828577,"eighty":34.921298,"marketCap":10596574014},{"date":"2021-05-14","current":20.981963,"twenty":15.539951,"median":22.792403,"eighty":31.049676,"marketCap":10874552759},{"date":"2021-05-21","current":21.079161,"twenty":15.539951,"median":22.729021,"eighty":30.708575,"marketCap":10924928820},{"date":"2021-05-28","current":20.860172,"twenty":15.539951,"median":22.690051,"eighty":29.251849,"marketCap":10811430948},{"date":"2021-06-04","current":20.326167,"twenty":15.539951,"median":22.66338,"eighty":29.066489,"marketCap":10534666084},{"date":"2021-06-11","current":21.902652,"twenty":15.539951,"median":22.570359,"eighty":28.938372,"marketCap":11351728409},{"date":"2021-06-18","current":20.856755,"twenty":15.539951,"median":22.546699,"eighty":28.823366,"marketCap":10809660055},{"date":"2021-06-25","current":21.30382,"twenty":15.539951,"median":22.529137,"eighty":28.697412,"marketCap":11041365313},{"date":"2021-07-02","current":21.353233,"twenty":15.539951,"median":22.480863,"eighty":28.609672,"marketCap":11066974842},{"date":"2021-07-09","current":21.646178,"twenty":15.539951,"median":22.461902,"eighty":28.493579,"marketCap":11218802761},{"date":"2021-07-16","current":20.636752,"twenty":15.539951,"median":22.408914,"eighty":28.160581,"marketCap":10695636677},{"date":"2021-07-23","current":20.462632,"twenty":15.539951,"median":22.362439,"eighty":28.079318,"marketCap":10605393577},{"date":"2021-07-30","current":19.943802,"twenty":15.539951,"median":22.307175,"eighty":27.989103,"marketCap":10336493527},{"date":"2021-08-06","current":228.431671,"twenty":15.539951,"median":22.306554,"eighty":27.980122,"marketCap":9174729642},{"date":"2021-08-13","current":216.434593,"twenty":15.539951,"median":22.306554,"eighty":27.980122,"marketCap":8692879005},{"date":"2021-08-20","current":203.271885,"twenty":15.539951,"median":22.306554,"eighty":27.980122,"marketCap":8164211991},{"date":"2021-08-27","current":202.738962,"twenty":15.539951,"median":22.306554,"eighty":27.980122,"marketCap":8142807689},{"date":"2021-09-03","current":208.494526,"twenty":15.539951,"median":22.306554,"eighty":27.989103,"marketCap":8373974141},{"date":"2021-09-10","current":204.962011,"twenty":15.539951,"median":22.306554,"eighty":28.079318,"marketCap":8232094203},{"date":"2021-09-17","current":202.845547,"twenty":15.539951,"median":22.306554,"eighty":28.15225,"marketCap":8147088550},{"date":"2021-09-24","current":206.088761,"twenty":15.539951,"median":22.306554,"eighty":28.15225,"marketCap":8277349011},{"date":"2021-10-01","current":197.896981,"twenty":15.539951,"median":22.306554,"eighty":28.336851,"marketCap":7948334325},{"date":"2021-10-08","current":207.032796,"twenty":15.539951,"median":22.306554,"eighty":28.514954,"marketCap":8315265201},{"date":"2021-10-15","current":214.234863,"twenty":15.539951,"median":22.306554,"eighty":28.855634,"marketCap":8604529042},{"date":"2021-10-22","current":220.538575,"twenty":15.539951,"median":22.306554,"eighty":28.974281,"marketCap":8857711346},{"date":"2021-10-29","current":202.571473,"twenty":15.539951,"median":22.306554,"eighty":29.465696,"marketCap":8136080623},{"date":"2021-11-05","current":205.647197,"twenty":15.539951,"median":22.307175,"eighty":38.033407,"marketCap":8259614018},{"date":"2021-11-12","current":-53.304535,"twenty":15.334919,"median":22.307175,"eighty":38.099501,"marketCap":8576859566},{"date":"2021-11-19","current":-49.041089,"twenty":15.19186,"median":22.307175,"eighty":38.099501,"marketCap":7890858328},{"date":"2021-11-26","current":-47.406004,"twenty":15.149879,"median":22.307175,"eighty":38.099501,"marketCap":7627768248},{"date":"2021-12-03","current":-45.942832,"twenty":14.992993,"median":22.307175,"eighty":38.099501,"marketCap":7392339507},{"date":"2021-12-10","current":-46.882624,"twenty":14.940831,"median":22.307175,"eighty":38.099501,"marketCap":7543554834},{"date":"2021-12-17","current":-47.864439,"twenty":14.904858,"median":22.307175,"eighty":38.099501,"marketCap":7701531822},{"date":"2021-12-23","current":-48.972324,"twenty":14.853801,"median":22.307175,"eighty":38.099501,"marketCap":7879793792},{"date":"2021-12-31","current":-48.670521,"twenty":14.753542,"median":22.307175,"eighty":38.099501,"marketCap":7831232773},{"date":"2022-01-07","current":-51.356186,"twenty":14.626899,"median":22.306864,"eighty":38.099029,"marketCap":8263364377},{"date":"2022-01-14","current":-55.126814,"twenty":14.584124,"median":22.306864,"eighty":38.099029,"marketCap":8870069773},{"date":"2022-01-21","current":-52.246314,"twenty":14.51891,"median":22.291453,"eighty":38.099029,"marketCap":8406588650},{"date":"2022-01-28","current":-52.032378,"twenty":14.422364,"median":22.291453,"eighty":38.099029,"marketCap":8372165649},{"date":"2022-02-04","current":-53.843196,"twenty":14.223531,"median":22.27218,"eighty":38.099029,"marketCap":8663531766},{"date":"2022-02-11","current":-54.229045,"twenty":14.132265,"median":22.189917,"eighty":38.099029,"marketCap":8725616107},{"date":"2022-02-18","current":-52.678007,"twenty":14.040482,"median":22.12737,"eighty":38.099029,"marketCap":8476049349},{"date":"2022-02-25","current":-53.178465,"twenty":13.972466,"median":22.109742,"eighty":38.099029,"marketCap":8556574584},{"date":"2022-03-04","current":-28.91913,"twenty":13.940317,"median":22.080345,"eighty":38.099029,"marketCap":9533711827},{"date":"2022-03-11","current":-28.967822,"twenty":13.867469,"median":22.040876,"eighty":38.099029,"marketCap":9549763925},{"date":"2022-03-18","current":-29.329264,"twenty":13.783843,"median":21.968511,"eighty":38.099029,"marketCap":9668919889},{"date":"2022-03-25","current":-30.095222,"twenty":13.705849,"median":21.933463,"eighty":38.099029,"marketCap":9921431748},{"date":"2022-04-01","current":-29.758126,"twenty":13.589272,"median":21.860937,"eighty":38.099029,"marketCap":9810301834},{"date":"2022-04-08","current":-31.031601,"twenty":13.549318,"median":21.794989,"eighty":38.099029,"marketCap":10230125953},{"date":"2022-04-14","current":-31.321879,"twenty":13.450679,"median":21.754606,"eighty":38.099029,"marketCap":10325821157},{"date":"2022-04-22","current":-30.525957,"twenty":13.411427,"median":21.659472,"eighty":38.099029,"marketCap":10063431083},{"date":"2022-04-29","current":-30.00533,"twenty":13.314049,"median":21.637622,"eighty":38.099029,"marketCap":9891797105},{"date":"2022-05-06","current":-21.145426,"twenty":13.178574,"median":21.610502,"eighty":38.099029,"marketCap":9512333236},{"date":"2022-05-13","current":-20.293458,"twenty":12.881793,"median":21.573299,"eighty":38.099029,"marketCap":9129072955},{"date":"2022-05-20","current":-20.576062,"twenty":12.577766,"median":21.475486,"eighty":38.099029,"marketCap":9256203194},{"date":"2022-05-27","current":-20.905767,"twenty":12.351439,"median":21.387948,"eighty":38.099029,"marketCap":9404521807},{"date":"2022-06-03","current":-21.011331,"twenty":12.181055,"median":21.327652,"eighty":38.099029,"marketCap":9452010395},{"date":"2022-06-10","current":-20.433648,"twenty":12.084535,"median":21.299229,"eighty":38.099029,"marketCap":9192137755},{"date":"2022-06-17","current":-19.836846,"twenty":11.871718,"median":21.132824,"eighty":38.099029,"marketCap":8923664534},{"date":"2022-06-24","current":-21.305419,"twenty":11.825322,"median":20.994404,"eighty":38.099501,"marketCap":9584306692},{"date":"2022-07-01","current":-22.011944,"twenty":11.79083,"median":20.915212,"eighty":38.099501,"marketCap":9902139261},{"date":"2022-07-08","current":-21.973079,"twenty":11.712989,"median":20.863685,"eighty":38.099501,"marketCap":9884655348},{"date":"2022-07-15","current":-21.853705,"twenty":11.637295,"median":20.849696,"eighty":38.099501,"marketCap":9830954757},{"date":"2022-07-22","current":-21.866198,"twenty":11.538484,"median":20.810988,"eighty":38.099501,"marketCap":9836574586},{"date":"2022-07-29","current":-21.662152,"twenty":11.434468,"median":20.636752,"eighty":38.099501,"marketCap":9744784040},{"date":"2022-08-05","current":-185.751135,"twenty":11.344316,"median":20.569748,"eighty":38.099501,"marketCap":9635282891},{"date":"2022-08-12","current":-189.811269,"twenty":11.27714,"median":20.449691,"eighty":38.099501,"marketCap":9845890167},{"date":"2022-08-19","current":-189.291669,"twenty":11.157183,"median":20.353101,"eighty":38.099501,"marketCap":9818937451},{"date":"2022-08-26","current":-188.349138,"twenty":11.095545,"median":20.083804,"eighty":38.099501,"marketCap":9770046476},{"date":"2022-09-02","current":-187.152848,"twenty":11.013431,"median":19.45687,"eighty":38.099501,"marketCap":9707992546},{"date":"2022-09-09","current":-184.47026,"twenty":10.96191,"median":19.265635,"eighty":38.099501,"marketCap":9568841310},{"date":"2022-09-16","current":-178.22297,"twenty":10.924789,"median":19.105809,"eighty":38.099501,"marketCap":9244781900},{"date":"2022-09-23","current":-154.273012,"twenty":10.856762,"median":18.986588,"eighty":38.099501,"marketCap":8002449692},{"date":"2022-09-30","current":-161.06407,"twenty":10.792014,"median":18.878263,"eighty":38.099501,"marketCap":8354715434},{"date":"2022-10-07","current":-164.097087,"twenty":10.68803,"median":18.634848,"eighty":38.099501,"marketCap":8512044084},{"date":"2022-10-14","current":-160.9674,"twenty":10.587591,"median":18.478633,"eighty":38.099501,"marketCap":8349700975},{"date":"2022-10-21","current":-163.142472,"twenty":10.335342,"median":18.316363,"eighty":38.099501,"marketCap":8462526302},{"date":"2022-10-28","current":-173.909078,"twenty":10.256933,"median":18.205626,"eighty":38.099501,"marketCap":9021011669},{"date":"2022-11-04","current":-176.942094,"twenty":10.172528,"median":18.08264,"eighty":38.099501,"marketCap":9178340318},{"date":"2022-11-11","current":-502.564704,"twenty":-19.785503,"median":17.938028,"eighty":38.099501,"marketCap":9391426628},{"date":"2022-11-18","current":-495.926739,"twenty":-19.897812,"median":17.840364,"eighty":38.099501,"marketCap":9267382977},{"date":"2022-11-25","current":-515.537377,"twenty":-20.33003,"median":17.735721,"eighty":38.099501,"marketCap":9633846960},{"date":"2022-12-02","current":-529.857859,"twenty":-20.506906,"median":17.577624,"eighty":38.099501,"marketCap":9901453820},{"date":"2022-12-09","current":-511.999375,"twenty":-20.705138,"median":17.486049,"eighty":38.099501,"marketCap":9567732324},{"date":"2022-12-16","current":-531.441536,"twenty":-20.942856,"median":17.416425,"eighty":38.099501,"marketCap":9931047990},{"date":"2022-12-23","current":-529.655688,"twenty":-21.130464,"median":17.339807,"eighty":38.099501,"marketCap":9897675840},{"date":"2022-12-30","current":-536.799082,"twenty":-21.334291,"median":17.269055,"eighty":38.099501,"marketCap":10031164439},{"date":"2023-01-06","current":-535.046928,"twenty":-21.545832,"median":17.236563,"eighty":38.099501,"marketCap":9998421952},{"date":"2023-01-13","current":-527.22963,"twenty":-21.667149,"median":17.118203,"eighty":38.099501,"marketCap":9852340090},{"date":"2023-01-20","current":-529.824164,"twenty":-21.826877,"median":16.972593,"eighty":38.099501,"marketCap":9900824156},{"date":"2023-01-27","current":-524.197057,"twenty":-21.973079,"median":16.80081,"eighty":38.099501,"marketCap":9795670402},{"date":"2023-02-03","current":-524.432924,"twenty":-22.102169,"median":16.670289,"eighty":38.099501,"marketCap":9800078044},{"date":"2023-02-10","current":-505.462496,"twenty":-28.649453,"median":16.602573,"eighty":38.099501,"marketCap":9445577663},{"date":"2023-02-17","current":-497.779978,"twenty":-28.876431,"median":16.508241,"eighty":38.099501,"marketCap":9302014453},{"date":"2023-02-24","current":-484.70622,"twenty":-29.09929,"median":16.477034,"eighty":38.099501,"marketCap":9057705132},{"date":"2023-03-03","current":-41.301386,"twenty":-29.485826,"median":16.429048,"eighty":38.099501,"marketCap":9253988551},{"date":"2023-03-10","current":-37.89258,"twenty":-29.709809,"median":16.38135,"eighty":38.099501,"marketCap":8490211505},{"date":"2023-03-17","current":-38.197846,"twenty":-29.998588,"median":16.297694,"eighty":38.099501,"marketCap":8558609450},{"date":"2023-03-24","current":-39.933341,"twenty":-30.270138,"median":16.238273,"eighty":38.099501,"marketCap":8947464430},{"date":"2023-03-31","current":-41.360743,"twenty":-30.53607,"median":16.182497,"eighty":38.099029,"marketCap":9267288151},{"date":"2023-04-06","current":-41.205284,"twenty":-31.048081,"median":16.098301,"eighty":38.099029,"marketCap":9232455865},{"date":"2023-04-14","current":-41.202457,"twenty":-34.09955,"median":16.042513,"eighty":38.099501,"marketCap":9231822551},{"date":"2023-04-21","current":-40.967854,"twenty":-38.455061,"median":15.9108,"eighty":38.099501,"marketCap":9179257464},{"date":"2023-04-28","current":-39.300196,"twenty":-39.054853,"median":15.838594,"eighty":38.099501,"marketCap":8805602027},{"date":"2023-05-05","current":-38.692491,"twenty":-39.2985,"median":15.648764,"eighty":38.099501,"marketCap":8669439452},{"date":"2023-05-12","current":-55.552322,"twenty":-39.454526,"median":15.514786,"eighty":38.099974,"marketCap":8682105738},{"date":"2023-05-19","current":-53.956063,"twenty":-39.922035,"median":15.275654,"eighty":38.099974,"marketCap":8432631214},{"date":"2023-05-26","current":-52.236021,"twenty":-40.52861,"median":15.174543,"eighty":38.099974,"marketCap":8163811092},{"date":"2023-06-02","current":-52.878989,"twenty":-40.7129,"median":15.04752,"eighty":38.100446,"marketCap":8264298613},{"date":"2023-06-09","current":-52.252403,"twenty":-41.004034,"median":14.977267,"eighty":38.100446,"marketCap":8166371283},{"date":"2023-06-16","current":-52.801178,"twenty":-41.202457,"median":14.936073,"eighty":38.100918,"marketCap":8252137703},{"date":"2023-06-23","current":-52.440352,"twenty":-41.318345,"median":14.903002,"eighty":38.150016,"marketCap":8195745310},{"date":"2023-06-30","current":-50.753626,"twenty":-41.537685,"median":14.853104,"eighty":38.174566,"marketCap":7932131965},{"date":"2023-07-07","current":-50.138033,"twenty":-46.22859,"median":14.766074,"eighty":38.174566,"marketCap":7835922715},{"date":"2023-07-14","current":-52.021749,"twenty":-46.879568,"median":14.628077,"eighty":38.174566,"marketCap":8130323020},{"date":"2023-07-21","current":-52.567575,"twenty":-47.50686,"median":14.589694,"eighty":38.174566,"marketCap":8215628555},{"date":"2023-07-27","current":-53.663331,"twenty":-48.315997,"median":14.52007,"eighty":38.174566,"marketCap":8386881020},{"date":"2023-08-04","current":-53.166752,"twenty":-49.032684,"median":14.415054,"eighty":38.199115,"marketCap":8309272225},{"date":"2023-08-11","current":-98.649512,"twenty":-49.523974,"median":14.211824,"eighty":38.199115,"marketCap":8534563886},{"date":"2023-08-18","current":-100.649066,"twenty":-50.058815,"median":14.128435,"eighty":38.199115,"marketCap":8707553271},{"date":"2023-08-25","current":-101.269365,"twenty":-50.396977,"median":14.038531,"eighty":38.199115,"marketCap":8761217861},{"date":"2023-09-01","current":-104.618982,"twenty":-50.816236,"median":13.965497,"eighty":38.199115,"marketCap":9051006648},{"date":"2023-09-08","current":-99.050882,"twenty":-51.1829,"median":13.935856,"eighty":38.199115,"marketCap":8569288032},{"date":"2023-09-15","current":-97.657033,"twenty":-51.424475,"median":13.862451,"eighty":38.199115,"marketCap":8448700541},{"date":"2023-09-22","current":-96.86159,"twenty":-51.817934,"median":13.777431,"eighty":38.199115,"marketCap":8379883596},{"date":"2023-09-29","current":-95.620991,"twenty":-52.029354,"median":13.684192,"eighty":38.199115,"marketCap":8272554416},{"date":"2023-10-06","current":-93.555759,"twenty":-52.224357,"median":13.583697,"eighty":38.199115,"marketCap":8093882898},{"date":"2023-10-13","current":-93.424401,"twenty":-52.49593,"median":13.54653,"eighty":38.199115,"marketCap":8082518632},{"date":"2023-10-20","current":-96.350755,"twenty":-52.670695,"median":13.429195,"eighty":38.199115,"marketCap":8335689228},{"date":"2023-10-27","current":-94.051998,"twenty":-52.796263,"median":13.412728,"eighty":38.256711,"marketCap":8136814570},{"date":"2023-11-03","current":-94.022808,"twenty":-53.077759,"median":13.31981,"eighty":38.256711,"marketCap":8134289178},{"date":"2023-11-10","current":91.7495,"twenty":-53.156093,"median":13.244546,"eighty":38.432333,"marketCap":7335739502},{"date":"2023-11-17","current":95.899172,"twenty":-53.156093,"median":13.244546,"eighty":38.700486,"marketCap":7667522434},{"date":"2023-11-24","current":95.55271,"twenty":-53.156093,"median":13.244546,"eighty":38.883662,"marketCap":7639821392},{"date":"2023-12-01","current":93.095978,"twenty":-53.156093,"median":13.244546,"eighty":39.035206,"marketCap":7443395823},{"date":"2023-12-08","current":94.135365,"twenty":-53.153908,"median":13.248728,"eighty":39.308081,"marketCap":7526498949},{"date":"2023-12-15","current":96.867692,"twenty":-53.153908,"median":13.248728,"eighty":39.543187,"marketCap":7744959437},{"date":"2023-12-22","current":95.355857,"twenty":-53.153908,"median":13.248728,"eighty":39.773572,"marketCap":7624082164},{"date":"2023-12-29","current":97.135413,"twenty":-53.156093,"median":13.244546,"eighty":40.05636,"marketCap":7766364787},{"date":"2024-01-05","current":97.914953,"twenty":-53.158278,"median":13.216206,"eighty":40.466144,"marketCap":7828692131},{"date":"2024-01-12","current":94.804667,"twenty":-53.158278,"median":13.216206,"eighty":42.631172,"marketCap":7580012325},{"date":"2024-01-19","current":90.702239,"twenty":-53.160463,"median":13.187866,"eighty":44.499321,"marketCap":7252006808},{"date":"2024-01-26","current":96.710209,"twenty":-53.158278,"median":13.216206,"eighty":44.912837,"marketCap":7732368054},{"date":"2024-02-02","current":97.387385,"twenty":-53.158278,"median":13.216206,"eighty":45.434552,"marketCap":7786510999},{"date":"2024-02-09","current":96.592097,"twenty":-53.158278,"median":13.216206,"eighty":45.838119,"marketCap":7722924517},{"date":"2024-02-16","current":99.859866,"twenty":-53.158278,"median":13.216206,"eighty":46.267803,"marketCap":7984195706},{"date":"2024-02-23","current":101.143351,"twenty":-53.158278,"median":13.216206,"eighty":46.765266,"marketCap":8086815474},{"date":"2024-03-01","current":18.04484,"twenty":-53.156093,"median":13.244546,"eighty":46.893984,"marketCap":7485576955},{"date":"2024-03-08","current":17.489298,"twenty":-53.156093,"median":13.244546,"eighty":46.893984,"marketCap":7255120582},{"date":"2024-03-15","current":17.779359,"twenty":-53.156093,"median":13.244546,"eighty":46.893984,"marketCap":7375446978},{"date":"2024-03-22","current":18.651043,"twenty":-53.156093,"median":13.244546,"eighty":46.893984,"marketCap":7737049620},{"date":"2024-03-28","current":18.111501,"twenty":-53.156093,"median":13.244546,"eighty":46.893984,"marketCap":7513230054},{"date":"2024-04-05","current":17.314961,"twenty":-53.158278,"median":13.216206,"eighty":46.912018,"marketCap":7182800054},{"date":"2024-04-12","current":17.056462,"twenty":-53.158278,"median":13.216206,"eighty":46.912018,"marketCap":7075566167},{"date":"2024-04-19","current":16.422236,"twenty":-53.158278,"median":13.216206,"eighty":46.912018,"marketCap":6812469073},{"date":"2024-04-26","current":16.145702,"twenty":-53.156093,"median":13.244546,"eighty":46.893984,"marketCap":6697753752},{"date":"2024-05-03","current":20.598064,"twenty":-53.156093,"median":13.244546,"eighty":46.893984,"marketCap":6813715979},{"date":"2024-05-10","current":21.557349,"twenty":-53.156093,"median":13.244546,"eighty":46.893984,"marketCap":7131041588},{"date":"2024-05-17","current":21.056148,"twenty":-53.156093,"median":13.244546,"eighty":46.893984,"marketCap":6965247392},{"date":"2024-05-24","current":19.80791,"twenty":-53.156093,"median":13.244546,"eighty":46.893984,"marketCap":6552337894},{"date":"2024-05-31","current":20.097578,"twenty":-53.156093,"median":13.244546,"eighty":46.893984,"marketCap":6648158114},{"date":"2024-06-07","current":20.261468,"twenty":-53.156093,"median":13.244546,"eighty":46.893984,"marketCap":6702372185},{"date":"2024-06-14","current":21.477309,"twenty":-53.158278,"median":13.216206,"eighty":46.912018,"marketCap":7104564948},{"date":"2024-06-21","current":20.467042,"twenty":-53.160463,"median":13.187866,"eighty":46.930051,"marketCap":6770374540},{"date":"2024-06-28","current":20.417475,"twenty":-53.16429,"median":13.168817,"eighty":46.974201,"marketCap":6753978327},{"date":"2024-07-05","current":19.736893,"twenty":-53.16429,"median":13.168817,"eighty":46.974201,"marketCap":6528845716},{"date":"2024-07-12","current":20.215398,"twenty":-53.16429,"median":13.168817,"eighty":46.974201,"marketCap":6687132230},{"date":"2024-07-15","current":20.12961,"twenty":-53.16429,"median":13.168817,"eighty":46.974201,"marketCap":6658754170},{"date":"2024-08-02","current":17.885382,"twenty":-53.178465,"median":12.842617,"eighty":47.17374,"marketCap":7063366473},{"date":"2024-08-09","current":17.664903,"twenty":-53.178465,"median":12.906324,"eighty":47.17374,"marketCap":6976294024},{"date":"2024-08-16","current":17.200489,"twenty":-53.178465,"median":13.187866,"eighty":47.17374,"marketCap":6792886100},{"date":"2024-08-23","current":17.911964,"twenty":-53.178465,"median":13.324456,"eighty":47.17374,"marketCap":7073864570},{"date":"2024-08-30","current":18.076151,"twenty":-53.178465,"median":13.415515,"eighty":47.17374,"marketCap":7138705756},{"date":"2024-09-06","current":16.948737,"twenty":-53.178465,"median":13.500071,"eighty":47.17374,"marketCap":6693462948},{"date":"2024-09-13","current":16.645383,"twenty":-53.178465,"median":13.566043,"eighty":47.17374,"marketCap":6573661139},{"date":"2024-09-20","current":17.402204,"twenty":-53.178465,"median":13.629227,"eighty":47.17374,"marketCap":6872548127},{"date":"2024-09-27","current":17.230199,"twenty":-53.178465,"median":13.761171,"eighty":47.17374,"marketCap":6804619266},{"date":"2024-10-04","current":16.975319,"twenty":-53.178465,"median":13.812276,"eighty":47.17374,"marketCap":6703961045},{"date":"2024-10-11","current":16.867425,"twenty":-53.178465,"median":13.882893,"eighty":47.17374,"marketCap":6661351123},{"date":"2024-10-18","current":17.924474,"twenty":-53.178465,"median":13.959086,"eighty":47.17374,"marketCap":7078804851},{"date":"2024-10-25","current":16.895572,"twenty":-53.178465,"median":14.035279,"eighty":47.17374,"marketCap":6672466755},{"date":"2024-10-31","current":17.69774,"twenty":-53.178465,"median":14.148639,"eighty":47.17374,"marketCap":6989262261},{"date":"2024-11-08","current":15.543113,"twenty":-53.203679,"median":14.578693,"eighty":47.175246,"marketCap":7198932815},{"date":"2024-11-15","current":16.220547,"twenty":-53.203679,"median":16.183124,"eighty":47.175246,"marketCap":7512692147},{"date":"2024-11-22","current":16.328884,"twenty":-53.203679,"median":16.250003,"eighty":47.175246,"marketCap":7562869459},{"date":"2024-11-29","current":15.870735,"twenty":-53.203679,"median":16.304172,"eighty":47.175246,"marketCap":7350673841},{"date":"2024-12-06","current":16.073051,"twenty":-53.203679,"median":16.304172,"eighty":47.175246,"marketCap":7444378458},{"date":"2024-12-13","current":16.133094,"twenty":-53.203679,"median":16.304172,"eighty":47.175246,"marketCap":7472187571},{"date":"2024-12-20","current":16.035199,"twenty":-53.203679,"median":16.33541,"eighty":47.175246,"marketCap":7426846627},{"date":"2024-12-27","current":16.422863,"twenty":-53.203679,"median":16.349022,"eighty":47.175246,"marketCap":7606396765},{"date":"2025-01-03","current":16.153978,"twenty":-53.203679,"median":16.349022,"eighty":47.175246,"marketCap":7481860305},{"date":"2025-01-10","current":15.693219,"twenty":-53.228893,"median":16.356108,"eighty":47.176752,"marketCap":7268455596},{"date":"2025-01-17","current":16.005178,"twenty":-53.228893,"median":16.356108,"eighty":47.176752,"marketCap":7412942071},{"date":"2025-01-24","current":15.986904,"twenty":-53.228893,"median":16.356108,"eighty":47.176752,"marketCap":7404478428},{"date":"2025-01-31","current":16.322357,"twenty":-53.228893,"median":16.356108,"eighty":47.176752,"marketCap":7559846729},{"date":"2025-02-07","current":15.672335,"twenty":-53.228893,"median":16.356108,"eighty":47.176752,"marketCap":7258782861},{"date":"2025-02-14","current":17.858656,"twenty":-53.228893,"median":16.422863,"eighty":47.176752,"marketCap":8271397277},{"date":"2025-02-21","current":17.836467,"twenty":-53.228893,"median":16.522931,"eighty":47.176752,"marketCap":8261119996},{"date":"2025-02-28","current":15.534425,"twenty":-53.228893,"median":16.592548,"eighty":47.176752,"marketCap":8701142266},{"date":"2025-03-07","current":14.794949,"twenty":-53.254107,"median":16.605832,"eighty":47.178258,"marketCap":8286946759},{"date":"2025-03-14","current":14.751578,"twenty":-53.254107,"median":16.605832,"eighty":47.178258,"marketCap":8262653767},{"date":"2025-03-21","current":15.241671,"twenty":-53.254107,"median":16.605832,"eighty":47.178258,"marketCap":8537164573},{"date":"2025-03-28","current":13.705251,"twenty":-53.254107,"median":16.605832,"eighty":47.178258,"marketCap":7676585345},{"date":"2025-04-04","current":13.100225,"twenty":-53.254107,"median":16.631892,"eighty":47.178258,"marketCap":7337698112}],"updateTime":1743912979617}}}